purified T cells, PBMC are incubated on nylon wool columns in 10% human serum RPMI 1640 with 25 mM Hepes and antibiotics and r.-glutamine, i.e ., complete tissue culture media (TCM). After 60 min at 37°C, nonadherent cells are eluted and depleted of adherent cells by incubation in 100-mm petri dishes (No. 1029 ; Falcon Labware, Oxnard, CA) overnight at 37°C in 5% C02 and air. Any residual nonT cells are removed from the petri dish nonadherent fraction by antibody plus complement depletion as previously described (9) 
Results and Discussion
Purified T cells used in these studies were assessed for functional purity by their inability to respond to OKT3 and a markedly reduced response to PHA (Table I) . That the T cells were functionally intact was verified by their response to these stimuli if irradiated, autologous PBMC, as a source of APC, were present in the culture system (i .e ., a "reconstituted response") . This "reconstituted" response to PHA or OKT3 was, in all cases, comparable to that of unseparated PBMC (Table I) .
Results shown in Table II from three separate experiments confirm earlier findings that purified human T cells do not respond proliferatively to mouse xenoantigens (6, 7) . Addition of autologous human PBMC (x-irradiated) as a source of APC to the human T cell-mouse spleen cell mixture reconstitutes a strong proliferative response to the BALB/c xenoantigens . This T cell response is always greater, in terms of cpm incorporated, than the response of human PBMC to murine stimulating cells (data not shown). In contrast, human T cells cultured in MLC with allogeneic irradiated PBMC respond proliferatively, as has been shown previously (1), and do not require additional "reconstituting" cells.
To understand the mechanism(s) whereby irradiated autologous PBMC reconstitute a T cell xenogeneic response, we used human cytokines to substitute for the human PBMC/APC . Data in Table II show that addition of rIL-1, rIL-2, or TCGF to the purified T cells allows a significant proliferative response to murine stimulating cells . As shown, the purified T cells in the absence of BALB/c stimulating cells do not respond to rIL-1 ; the response to rIL-2 or TCGF alone is very weak compared with the response in the presence of both the cytokine and the BALB/c cells.
We then used a PIT approach (10) to evaluate the immunogenetic specificity of the human T cell proliferative response to BALB/c xenoantigens . Purified human T cells were cultured with BALB/c-irradiated splenic stimulating cells in the absence or presence of autologous, irradiated PBMC or rIL-1 or rIL-2 or TCGF. After 10 d of culture, the primed responding cells were restimulated with irradiated cells from several sources. Results are shown in Table III . T cells primed to BALB/c in the presence of APBMC x or rIL-1, or rIL-2, or TCGF show a highly significant secondary proliferative response to BALB/c restimulating cells as is expected if the primary proliferative response was specifically to BALB/c antigens; there is no proliferative response to stimulating cells ofother mouse strains, B10.% or B10.BRx. These results demonstrate that cells proliferating in the primary human anti-mouse MLC in the presence of rIL-1, rIL-2, or TCGF respond in an antigen-specific manner. The relatively low level proliferation seen on day 2 in response to allogeneic human cells (BPBMC x) in the PIT probably reflects the onset of a primary allogeneic response of unprimed T cells present in the responding population. We cannot rule out shared specificities between mouse and human stimulating antigens that may also contribute to the allogeneic proliferative response .
The lack of any response to the third-party murine stimulator cells in the PIT Exp. 1003 : rIL-1, 10 U/ml ; rIL-2, 10 A/ml ; TCGF, 10% . : Exp. 1005: rIL-1, 10 U/ml ; rIL-2, 40 u/ml ; TCGF, 10% . 5 Exp. 1006: rIL-1, 9 U/ml ; rIL-2, 200 u/ml ; TCGF, 10% .
Purified T cells of a different individual were used as responding cells in each experiment . compared with the positive allogeneic response may be based on the need, as demonstrated in the primary response, for human cytokines to permit a human anti-mouse response . These data, in aggregate, suggest that the cytokine requirements differ for the primary and secondary xenogeneic responses. It was clear from earlier results that human T cells can respond to murine antigens in the presence of human APC. Such a response could be based solely on recognition of murine peptides presented by those self-APC . The present results demonstrate that an antigen-specific human anti-mouse response based on direct recognition of the murine antigens in the presence of human cytokines does occur, i.e ., that the human T cell repertoire includes receptors that permit direct recognition of murine antigens .
While the data shown here address the issue of the human T cell repertoire vis-avis recognition of highly disparate xenogeneic antigens, they do not provide direct information regarding the extent to which that repertoire may be quantitatively limited compared with the repertoire that recognizes alloantigens . The data also do not address the issue of the ability of human CD4 and CD8 molecules or of other human cell surface molecules to interact significantly with the murine homologues of their human ligands.
Our initial hypothesis for this study was that there is no response of purified human T cells to murine xenoantigens because there is a need for an APC-produced cytokine, such as IL-1, to allow the response to take place, and the murine IL-1 would not provide an adequate stimulus to the human cells under these conditions (6) . Our finding that the addition of human rIL-1 to these cultures allowed a response suggests that this may be a reasonable explanation.
In the past we have presented evidence that the proliferative response in human anti-mouse MLC (in which both responder and stimulator APC were present) was very largely directed against class II antigens of H-2 (6). In that system, however, it was not clear whether the class II antigens were being recognized directly or indirectly ; it is at least possible that the majority, or all, of that response was an indirect response in which murine class II peptides were presented on human, autologous APC . In the present studies, there is, by definition, direct recognition of the murine xenoantigens . Experiments are currently in progress to evaluate which class(es) of antigens are recognized and which subpopulations of human T cells are responding under these conditions . Based on studies of alloantigen recognition, we proposed that stimulation of precursor T cells with alloantigen alone (signal 1 to the T cell) drove those cells along the pathway of maturation to become "poised" to receive help in the form of what is now recognized to be IL-2 by upregulating receptors for IL-2 (11) . We would suggest from the data reported herein that direct recognition by human T cells of murine xenoantigens does occur, and results in the delivery of a signal I to the human T cells that then renders the T cells responsive to subsequent addition of rIL-1 (12) or rIL-2.
Summary
Purified human T cells respond proliferatively to allogeneic peripheral blood mononuclear (PBMC) stimulating cells but show no response to murine splenic stimulating cells. Two possible explanations for the lack of xenogeneic response are that human T cells, educated in a human thymus, cannot directly recognize a molecule as disparate as mouse antigen encoded by H-2 and/or that a cytol.ine(s) produced by the APCs is needed to allow a proliferative response and that the cytokine(s) produced by murine APC do not provide an adequate stimulus to the human T cells under these conditions. We show here that highly purified human T cells can respond directly in an antigen-specific manner to murine stimulating cells ifhuman rIL-1 or rIL-2 or a T cell growth factor (TCGF) preparation are present in the culture. These findings demonstrate that human T cells can recognize murine antigens and that a highly significant response can be obtained ifa human cytokine is present to permit that response.
